Citations

Mayo Clinic

Showing 10 of 108602 citations.

Considering health equity when moving from evidence-based guideline recommendations to implementation: a case study from an upper-middle income country on the GRADE approach
Eslava‐Schmalbach, Javier , Mosquera, Paola A. , Álzate, Juan Pablo , Jull, Janet , Katikireddi, Srinivasa Vittal , Morton, Rachel L, Thabane, Lehana , Shea, Bev , Singh, Jasvinder A. , Flórez, Iván D. , Schünemann, Holger J. , Singh, Jasvinder, Singh, Jasvinder A , Schünemann, Holger J , Thabane, Lehana , Pottie, Kevin , Welch, Vivian Andrea , Akl, Elie A. , Lang, Eddy , Stein, Aírton Tetelbom , Guyatt, Gordon , Tugwell, Peter

Health Policy and Planning | August 26, 2017 | Volume: 32 | Issue: 10 | Pages: 1484-1490

10.1093/heapol/czx126 | PMID 29029068 Get It

Brain calcification in a CSF1R mutation carrier precedes white matter degeneration
Broderick, Daniel F. , Wszołek, Zbigniew K. , Konno, Takuya , Wszolek, Z.K.

Movement Disorders | August 26, 2017 | Volume: 32 | Issue: 10 | Pages: 1493-1495

10.1002/mds.27130 | PMID 28843019 Get It

Clinicopathologic discrepancies in a population‐based incidence study of parkinsonism in olmsted county: 1991‐2010
Turcano, Pierpaolo , Mielke, Michelle M. , Josephs, Keith A. , Bower, James H., Parisi, Joseph E. , Savica, Rodolfo , Mielke, Michelle M , Boeve, Bradley F.

Movement Disorders | August 26, 2017 | Volume: 32 | Issue: 10 | Pages: 1439-1446

10.1002/mds.27125 | PMID 28843020 Get It

ABSTRACTObjective: The purpose of this study was to examine the discrepancies between the clinical diagnosis of parkinsonism and neuropathological findings in a population‐based cohort with parkinsonian disorders.Background: The specific clinical diagnosis of parkinsonism is challenging, and definite confirmation requires neuropathological evaluation. Currently, autopsies are seldom performed, and most brain autopsies represent atypical or diagnostically unresolved cases.Methods: We used a defined population‐based incidence cohort with clinical parkinsonism (n = 669) from the Rochester Epidemiology Project in Olmsted County, Minnesota, 1991‐2010. We reviewed reports of all patients who underwent neuropathologic examination at autopsy (n = 60; 9%) and applied consensus pathologic guidelines for neurodegenerative disease diagnosis.Results: Among the 60 patients examined pathologically, the median time from the last recorded clinical diagnosis to death was 7 years (range from 2 to 17 years). Clinical–pathological concordance was found in 52 cases (86.7%), whereas 8 (13.3%) had a clinical‐pathological discrepancy. Four patients with a clinical diagnosis of idiopathic Parkinson's disease had no pathological evidence of Lewy bodies or α‐synucleinopathy; of these, pathological diagnoses were Alzheimer's disease (2 cases), progressive supranuclear palsy (1 case), and vascular parkinsonism (1 case). Two patients with clinical diagnoses of "dementia with Lewy bodies" and one patient with an "unspecified parkinsonism" had a pathological diagnosis of Alzheimer's disease without concomitant α‐synuclein lesions. One patient with clinically diagnosed "progressive supranuclear palsy" had indeterminate pathological findings without α‐synuclein or Aβ‐ or tau‐immunoreactive lesions at autopsy.Conclusions: Overall, the clinical diagnoses of parkinsonian subtypes had good concordance with pathological confirmation (86.7%). However, clinical–pathological discrepancies were documented in 13.3%. © 2017 International Parkinson and Movement Disorder Society
Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population
Reiffel, James A. , Kowey, Peter R. , Halperin, Jonathan L. , Wachter, Rolf , Pouliot, Erika , Ziegler, Paul , Investigators, for the REVEAL AF, Verma, Atul , Gersh, Bernard J. , Investigators, for the REVEAL AF

JAMA Cardiology | August 26, 2017 | Volume: 2 | Issue: 10 | Pages: 1120

10.1001/jamacardio.2017.3180 | PMID 28842973 Get It

Neurotization of the Superficial Sensory Branch of Ulnar Nerve by the Distal Posterior Interosseous Nerve: Cadaveric Feasibility Study
Decaestecker, Laurent, Delclaux, Stépahnie, Aprédoaei, C., Tibbo, Meagan E. , Courtade-Saïdi, Monique , Mansat, Pierre , Laumonerie, Pierre , Laumonerie, Pierre

Journal of Reconstructive Microsurgery | August 25, 2017 | Volume: 33 | Issue: 09 | Pages: 636-640

10.1055/s-0037-1605365 | PMID 28841737 Get It

Background In 2014, Delclaux et al described a case wherein the Battiston and Lanzetta's technique, modified by utilization of the posterior interosseus nerve (PIN), was used to perform double neurotization of the ulnar nerve (UN). This study evaluates the feasibility of transfer of proprioceptive fascicles of the PIN to the superficial sensory branch of the UN (SSBUN). Methods The surgeries were performed on 16 fresh cadaveric wrist specimens. PIN transfer was performed through the interosseous membrane and sutured to the SSBUN. The diameter for each nerve, number of fascicles, and the percentage of fascicles without axons, under ×10, ×40, and ×100 magnifications were performed by two observers. Results Neurotization of the SSBUN by the PIN was successful in all cases. The median diameter of the SSBUN and PIN was 3.5 (3–4) and 2.3 mm (1.6–3), respectively. The SSBUN contained 5.5 fascicles (4–7), while the PIN contained 2 fascicles (0–4). The 16 PIN had limited (10 cases) or no axonal reserve (6 cases). Conclusion This study supports the surgical and anatomical feasibility of neurotization of the SSBUN by the PIN. However, the PIN's limited axonal reserve may partially or totally compromise recovery.
Faculty Opinions recommendation of Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.
Coddington, Charles C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | August 25, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.728684802.793535623 Get It

Rationale and design of the Drug‐Eluting Stents vs Bare‐Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial
Brilakis, Emmanouil S. , Edson, Robert , Shunk, Kendrick , Goldman, Steven , Holmes, David R. , Bhatt, Deepak L. , Smith, Mark W. , Sather, Mike R., Colling, Cindy, Kar, Biswajit , Nielsen, Lori, Conner, T., Wagner, Todd H. , Rangan, Bavana V. , Ventura, Beverly, Lü, Ying , Holodniy, Mark , Shih, Mei‐Chiung, Brilakis, Emmanouil S , Bhatt, Deepak L , Lu, Ying , Banerjee, Subhash , Rao, Sunil V.

Clinical Cardiology | August 25, 2017 | Volume: 40 | Issue: 11 | Pages: 946-954

10.1002/clc.22763 | PMID 28841230 Get It

VA Cooperative Studies Program #571 (DIVA) was designed to evaluate the efficacy of drug‐eluting stents (DES) for reducing aortocoronary saphenous vein bypass graft (SVG) failure when compared with bare‐metal stents (BMS) in participants undergoing stenting of de novo SVG lesions. Participants undergoing clinically indicated stenting of de novo SVG lesions were randomized in a 1:1 ratio to DES or BMS. Randomization was stratified by presence/absence of diabetes mellitus and the number of target SVG lesions (1 vs ≥2) within each participating site. At sites that did not routinely administer 12‐months of dual antiplatelet therapy after SVG stenting participants without acute coronary syndromes received 1 month of open‐label clopidogrel, followed by 11 months of clopidogrel for those assigned to DES and 11 months of placebo for those assigned to BMS. The primary endpoint was the 12‐month incidence of target‐vessel failure (defined as the composite of cardiac death, target‐vessel myocardial infarction, or target‐vessel revascularization). Secondary endpoints included the incidence of other clinical endpoints and the incremental cost‐effectiveness of DES relative to BMS. Due to lower‐than‐anticipated target‐vessel failure rates, target enrollment was increased from 519 to 762. The study had randomized 599 participants when recruitment ended in December 2015. The DIVA trial will provide clarity on the appropriate stent type for de novo SVG lesions.
Analysis of patient-detected breast cancer recurrence
Kapoor, Trishul , Wrenn, Sean M. , James, Ted A. , CALLAS, PETER W.

Breast Disease | August 25, 2017 | Volume: 37 | Issue: 2 | Pages: 77-82

10.3233/bd-170288 | PMID 28854486 Get It

Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin sensitivity
McGee‐Lawrence, Meghan E. , Pierce, Jessica L. , Yu, Kanglun , Culpepper, Natasha R., Bradley, Elizabeth W. , Bradley, Elizabeth W , Westendorf, Jennifer J. , McGee-Lawrence, Meghan E

Journal of Cellular Physiology | August 25, 2017 | Volume: 233 | Issue: 4 | Pages: 2671-2680

10.1002/jcp.26148 | PMID 28840938 Get It

Type 2 diabetes is an emerging global health epidemic. Foundations for new therapies are arising from understanding interactions between body systems. Bone‐derived factors that reduce RANKL (receptor activator of NF‐kappa B ligand) signaling in the liver may prevent insulin resistance and the onset of type 2 diabetes. Here we demonstrate that deletion of the epigenetic regulator, Hdac3, in Osx1‐expressing osteoprogenitors prevents insulin resistance induced by high fat diet by increasing serum and skeletal gene expression levels of osteoprotegerin (Opg), a natural inhibitor of RANKL signaling. Removal of one Opg allele in mice lacking Hdac3 in Osx1+ osteoprogenitors increases the insulin resistance of the Hdac3‐deficient mice on a high fat diet. Thus, Hdac3‐depletion in osteoblasts increases expression of Opg, subsequently preserving insulin sensitivity. The Hdac inhibitor vorinostat also increased Opg transcription and histone acetylation of the Opg locus. These results define a new mechanism by which bone regulates systemic insulin sensitivity.